UPC preparations now begin in earnest. On 19 January 2022, the protocol on the UPC provisional application phase (“PAP”) came into force. The agreement regarding the Unified Patent Court or the UPC is now expected to enter into force at some point around 1 January 2023 (between the end of 2022 and the beginning of 2023). Following many obstacles to the Unified Patent Court, the last practical preparations are now starting.
The UPC will entail great changes for patent proprietors and tech-heavy companies. The UPC Agreement entails that in the future a large number of patent cases will commence in UPC divisions instead of in the ordinary national courts. A European unitary patent will be implemented along with the patent court agreement; meaning a patent with unitary effect in the entire EU with the exception of Spain, Poland, the Czech Republic, Hungary and Croatia. Great Britain is not comprised by the UPC or the unitary patent either.
According to the plan, the UPC was supposed to start in 2017; however, the project has been delayed due to two proceedings before the German constitutional court questioning the UPC’s compatibility with the German constitution. On 20 March 2020, the German constitutional court found the German implementation of the UPC unconstitutional (passed without the necessary majority); however, the dispute was remedied, and on 9 July 2021 the constitutional court rejected two requests for a preliminary injunction against the German laws ratifying the UPC Agreement.
Great Britain originally stated that the country wanted to participate in the UPC despite Brexit. However, in early 2020 Great Britain announced that the country would not join the UPC after all.
Now, following the ratification of the protocol on the UPC provisional application phase (“PAP”) by thirteen countries, PAP has come into effect and the final UPC preparations have started.
On this website, you can keep updated on and find information about the UPC.
The UPC train is back on track, and with the new German ruling rejecting to put the ratification on hold, we are one step closer to joint enforcement and invalidation of European patents in all UPC Contracting Member States in one trial.
This Friday, the German Federal Constitutional Court, "Bundesverfassungsgericht" ("BVerfG") declared the German ratification of the agreement on the Unified Patent Court (UPC) unconstitutional. It means that for the present time Germany's ratification of the agreement has been postponed for an indefinite period. As Germany's ratification is necessary for the UPC agreement to enter into force, the entering into force of the system has also been postponed for an indefinite period.
The UK has announced that it does not wish to participate in the Unified Patent Court (UPC) This will solve a number of problems but will at the same time create new ones.
A new announcement from the German government raises further doubts as to when the Unified Patent Court (UPC) may enter into force. The German government believes that the uncertainty about the legal consequences of Brexit and the implications to a European patent reform should be examined more closely. The UPC is now expected to enter into force during 2020 at the earliest.
Brexit is imminent, and it is still not clear whether the UK and the EU will manage to secure a Brexit agreement prior to 29 March 2019, when according to the plans the UK leaves the EU. Consequently, to address the uncertainties, the UK government has published guidance on the legal rights of the patent holder in case the parties do not reach an agreement. In general, the patent holders can breathe again; in case of a no-deal scenario, the rules and systems will basically be the same as now.
The Munich-based Max Planck Institute recently published a comprehensive report addressing the issue of whether the Unified Patent Court (UPC) would be incompatible with EU law post Brexit. The report concluded that the UK remaining in the UPC system post Brexit would be incompatible with EU law.
The UK has recently ratified the agreement on a unified patent court (the UPC Agreement). The UK is one of the three countries that have to ratify the UPC Agreement before it can enter into force. Following the UK’s ratification, only Germany’s ratification remains outstanding before the UPC Agreement can enter into force.
Plesner has just taken part in a large European mock trial concerning patent infringement. The mock trial was part of the European patent judges' preparations for the future Unified Patent Court (UPC).
The new patent system includes a new unitary patent and a European patent court (UPC) The new system gives rise to a number of questions in relation to supplementary protection certificates, which is the subject of an article by Attorney-at-Law, Partner Mikkel Vittrup and Attorney-at-Law Peter Nørgaard in the new issue of the trade journal Dansk Biotek.
While the UK has taken a decisive step towards ratification of the Unified Patent Convention, Germany's ratification is in danger of being delayed due to legal proceedings before the German Constitutional Court. This may further delay the coming into effect of the new unitary patent agreement.
When the patent reform comes into effect in early 2018, the so-called unitary patent will be introduced into European patent law. The unitary patent makes it less expensive and easier for patent holders to enforce their rights across borders. However, the unitary patent will be subject to a number of restrictions that should be taken into account, in particular during the start-up phase. Attorney-at-Law, Partner Jeppe Brinck-Jensen and Attorney-at-law Peter Nørgaard are the authors of an article about the future unitary patent in the new issue of the Danish trade journal Dansk Biotek.
On 23 June 2016, the UK voted to leave the EU. On 28 November 2016, the UK surprisingly announced that it would ratify the Unified Patent Court Agreement. Sture Rygaard, Attorney and Plesner Partner, and Peter Nørgaard, Attorney, write about Brexit and the challenges of the UK joining the UPC in the new edition of the Danish trade paper Dansk Biotek.